Skip to main content

Closed

ANAB: AnaptysBio, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Revenue growth+432.0% / yr

Operating margin17.6%

ROIC14.1%

Financially safe

Stretched

Debt / equity21.76×

Interest coverage0.5×

Current ratio7.58×

AnaptysBio, Inc.

ANABNASDAQ·USD·Closed

AnaptysBio, Inc.

ANABNASDAQ·USD·Closed

$53.36

−3.05%

$53.36

−$1.68 (3.05%)

52W Range

69thpctl

Volume

0.66×avg

Mkt Cap

2.30BUSD

P/E

-62.8TTM

Div Yield

–ann

52W Range

69thpctl

Volume

0.66×avg

Market Cap

2.30BUSD

P/E Ratio

-62.8TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings